Idiopathic hemihypertrophy

Mabrook A Mohanna1, Abdul Khalig Sallam

  • 1Department of Pediatrics, Faculty of Medicine and Health Sciences, Sana'a University, PO Box 18660, Sana'a, Yemen. E-mail: mabrookmohanna@yahoo.com / draks601@yahoo.com.

Saudi Medical Journal
|April 22, 2014
PubMed

Insights

Idiopathic hemihypertrophy in Yemeni children is linked to a higher risk of embryonal tumors. This study highlights four cases in Sana

Area of Science:

  • Pediatric Oncology
  • Genetics
  • Developmental Biology

Background:

  • Idiopathic hemihypertrophy (IHH) is a rare congenital condition characterized by asymmetric overgrowth.
  • IHH is associated with an increased risk of embryonal tumors, necessitating vigilant monitoring.
  • Understanding IHH prevalence and associated conditions in diverse populations is crucial for early diagnosis and management.

Observation:

  • Four cases of IHH were identified in Yemeni children over three years in Sana'a.
  • Two cases presented with isolated hemihypertrophy.
  • Two cases exhibited hemihypertrophy alongside other significant medical conditions, including Wilms' tumor and ureteropelvic junction stricture with renal anomalies.

Findings:

  • The study identified left-sided hemihypertrophy in three cases and right-sided in one.
  • One case of left-sided hemihypertrophy was associated with Wilms' tumor.
  • Another case of right-sided hemihypertrophy presented with polydactyly, ureteropelvic junction stricture, hydronephrosis, and renal agenesis.

Implications:

  • This case series underscores the importance of recognizing hemihypertrophy as a potential indicator for embryonal tumors in pediatric populations.
  • Early detection and management of associated anomalies in children with hemihypertrophy can improve patient outcomes.
  • Further research is warranted to explore the genetic and environmental factors contributing to hemihypertrophy and its tumor predisposition in different ethnic groups.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
54
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
906